Brief: Interpace Biosciences Receives Nasdaq Deficiency Notice Due To Delayed Filing Of Form 10-Q
19/11/2020 21:14
Nov 19 (Reuters) - Interpace Biosciences Inc IDXG.O :
* INTERPACE BIOSCIENCES RECEIVES NASDAQ DEFICIENCY NOTICE
DUE TO
DELAYED FILING OF FORM 10-Q; NO IMMEDIATE IMPACT ON LISTING
Source text for Eikon: ID:nGNX9NBBpv
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million